VOLKAN, M. Et Al. 2017. Eucaryotic elongation factor 2kinaze is a novel therapeutic target in BRCA1 mutated breast cancer. AACR , 1125.

VOLKAN, M., GÜRAY, N. T., Asik, E., Lopez-Berestein, G., Ozpolat, B., & Kahraman, N., (2017). Eucaryotic elongation factor 2kinaze is a novel therapeutic target in BRCA1 mutated breast cancer . AACR (pp.1125).

VOLKAN, MÜRVET Et Al. "Eucaryotic elongation factor 2kinaze is a novel therapeutic target in BRCA1 mutated breast cancer," AACR, 2017

VOLKAN, MÜRVET Et Al. "Eucaryotic elongation factor 2kinaze is a novel therapeutic target in BRCA1 mutated breast cancer." AACR , pp.1125, 2017

VOLKAN, M. Et Al. (2017) . "Eucaryotic elongation factor 2kinaze is a novel therapeutic target in BRCA1 mutated breast cancer." AACR , p.1125.

@conferencepaper{conferencepaper, author={MÜRVET VOLKAN Et Al. }, title={Eucaryotic elongation factor 2kinaze is a novel therapeutic target in BRCA1 mutated breast cancer}, congress name={AACR}, city={}, country={}, year={2017}, pages={1125} }